Nee, Cyproteronacetaat mag niet zomaar worden gegeven zonder medisch onderzoek en medische geschiedenis. Ook medicijngebruik moet worden bekeken omdat dit medicijn andere medicijnen kan beïnvloeden. Een bloedtest is een vereiste, gezien Cyproteronacetaat de lever kan slopen. Cyproteronacetaat is trouwens niet goedgekeurd door de Amerikaanse FDA, en ik denk dat dat voldoende zegt. Om een FDA licentie te krijgen hoeft men alleen maar aan te tonen dat een medicijn onschadelijk is met zo min mogelijk (nihil) bijwerkingen (=dat je er niet dood van gaat), en dat kan men niet.
Cardiovascular: hypotension, tachycardia, heart failure, syncope, myocardial infarct, hemorrhage, cerebrovascular accident, cardiovascular disorder, retinal vascular disorder, embolus, pulmonary embolism, superficial and deep thrombophlebitis, thrombosis, retinal vein thrombosis, phlebitis, vascular headache and shock.
Gastrointestinal: constipation, diarrhea, indigestion, anorexia, nausea, vomiting, cholestatic jaundice, cirrhosis of liver, hepatic coma, hepatitis, hepatoma, hepatomegaly, jaundice, liver carcinoma, liver failure, abnormal liver function test, liver necrosis, pancreatitis and glossitis.
Hematology: increased fibrinogen, decreased prothrombin, thrombocytopenia, anemia, hemolytic anemia, hypochromic anemia, normocytic anemia, leukopenia and leukocytosis.
Metabolism: negative nitrogen balance, decreased response to ACTH, hyperglycemia, lowered cortisol, hypercalcemia, increased AST, increased ALT, increased creatinine, hypernatremia, edema, weight gain, weight loss and diabetes mellitus.
Musculoskeletal: myasthenia, osteoporosis.
Nervous System: fatigue, lassitude, weakness, hot flashes, increased sweating, aphasia, coma, depression, dizziness, encephalopathy, hemiplegia, personality disorder, psychotic depression, abnormal gait and headache.
Respiratory: asthma, increased cough, dyspnea, hyperventilation, respiratory disorder, shortness of breath on effort and lung fibrosis.
Skin: eczema, urticaria, erythema nodosum, exfoliative dermatitis, rash, maculopapular rash, dryness of the skin, pruritus, alopecia, hirsutism, skin discolouration, photosensitivity reactions and scleroderma.
Sensory System: ear disorder, optic atrophy, optic neuritis, abnormality of accommodation, abnormal vision, blindness and retinal disorder.
Urogenital: enlarged uterine fibroids, uterine hemorrhage, increased urinary frequency, bladder carcinoma, kidney failure, hematuria, urate crystalluria, urine abnormality.
Other: ascites, allergic reaction, asthenia, chills, fetal chromosome abnormality, death, fever, hernia, malaise and injection site reaction.